By Busola Bamidele
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised an alarm over the circulation of unregistered or falsified Oxytocin injections, warning that they endanger the lives of mothers and newborns.
In a statement via its official X handle, NAFDAC said such counterfeit products may carry incorrect doses, no active ingredient, or harmful contaminants resulting in weak uterine contractions, postpartum haemorrhage (PPH), and possible maternal death.
Read also:
- NASENI innovation signals new business opportunities
- YMR fuels youth MSMEs nationwide with ₦24m growth grants
- Nigeria positions economy as SME gateway for Europe Africa trade
- Tax reforms committee engages Ombud to protect SMEs
- Cashew sector could unlock $10bn SME opportunity
The agency added that substandard oxytocin can fail to stop bleeding after childbirth, increasing the likelihood of emergency interventions, including blood transfusions or surgery.
Healthcare professionals and the public are urged to report suspected cases of substandard or falsified medicines and devices to the nearest NAFDAC office, call 0800-162-3322, or email sf.alert@nafdac.gov.ng.
